Explore
Validate
Learn
ELISA
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 21714-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- Thyroglobulin antibody
- Antibody type
- Polyclonal
- Description
- Thyroglobulin antibody (Cat. #21714-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references HIF1A acts as target of XiHuang Pill in the treatment of papillary thyroid cancer by regulating dedifferentiation.
Public Cohort Analysis Identifies Thyroglobulin Variants as Hypothyroidism Risk Factors.
TRx0237 induces apoptosis and enhances anti-PD-1 immunotherapeutic efficacy in anaplastic thyroid Cancer.
Manganese-Loaded pH-Responsive DNA Hydrogels Enable Tg-Guided Thyroid Tumor Targeted Magnetic Resonance Imaging.
Time-resolved interactome profiling deconvolutes secretory protein quality control dynamics.
Thyroid cancer risk associated with perfluoroalkyl carboxylate exposure: Assessment using a human dermal fibroblast-derived extracellular matrix-based thyroid cancer organoid.
Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer.
Differential contributions of choline phosphotransferases CPT1 and CEPT1 to the biosynthesis of choline phospholipids.
Thyroglobulin Interactome Profiling Defines Altered Proteostasis Topology Associated With Thyroid Dyshormonogenesis.
HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E.
Yu XZ, Zhu WL, Qian HC, Sun CJ
Frontiers in chemistry 2025;13:1607067
Frontiers in chemistry 2025;13:1607067
Public Cohort Analysis Identifies Thyroglobulin Variants as Hypothyroidism Risk Factors.
Hermanson JN, Hudson AD, Plate L
bioRxiv : the preprint server for biology 2025 Nov 24;
bioRxiv : the preprint server for biology 2025 Nov 24;
TRx0237 induces apoptosis and enhances anti-PD-1 immunotherapeutic efficacy in anaplastic thyroid Cancer.
Ning Q, Liu J, Liu S, Zou Q, Li K, Li Z
International immunopharmacology 2025 May 16;155:114610
International immunopharmacology 2025 May 16;155:114610
Manganese-Loaded pH-Responsive DNA Hydrogels Enable Tg-Guided Thyroid Tumor Targeted Magnetic Resonance Imaging.
Hu Q, Ren A, Zhang X, Tang Z, Wang R, Wang DY, Huang T, Liu J, Ming J
ACS applied materials & interfaces 2025 Mar 5;17(9):13403-13414
ACS applied materials & interfaces 2025 Mar 5;17(9):13403-13414
Time-resolved interactome profiling deconvolutes secretory protein quality control dynamics.
Wright MT, Timalsina B, Garcia Lopez V, Hermanson JN, Garcia S, Plate L
Molecular systems biology 2024 Sep;20(9):1049-1075
Molecular systems biology 2024 Sep;20(9):1049-1075
Thyroid cancer risk associated with perfluoroalkyl carboxylate exposure: Assessment using a human dermal fibroblast-derived extracellular matrix-based thyroid cancer organoid.
Yoo MH, Kim Y, Lee BS
Journal of hazardous materials 2024 Nov 5;479:135771
Journal of hazardous materials 2024 Nov 5;479:135771
Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer.
Pan Z, Lu X, Xu T, Chen J, Bao L, Li Y, Gong Y, Che Y, Zou X, Tan Z, Huang P, Ge M
Cancer letters 2024 Jan 1;580:216496
Cancer letters 2024 Jan 1;580:216496
Differential contributions of choline phosphotransferases CPT1 and CEPT1 to the biosynthesis of choline phospholipids.
Horibata Y, Sugimoto H
Journal of lipid research 2021;62:100100
Journal of lipid research 2021;62:100100
Thyroglobulin Interactome Profiling Defines Altered Proteostasis Topology Associated With Thyroid Dyshormonogenesis.
Wright MT, Kouba L, Plate L
Molecular & cellular proteomics : MCP 2021;20:100008
Molecular & cellular proteomics : MCP 2021;20:100008
HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E.
Cheng L, Jin Y, Liu M, Ruan M, Chen L
Oncotarget 2017 Mar 21;8(12):19843-19854
Oncotarget 2017 Mar 21;8(12):19843-19854
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human thyroid cancer using 21714-1-AP(TG antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The Thyroglobulin antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human Thyroglobulin. This antibody recognizes human antigen. The Thyroglobulin antibody has been validated for the following applications: ELISA, IHC analysis.
